Journal
JOURNAL OF GENERAL PHYSIOLOGY
Volume 150, Issue 8, Pages 1081-1105Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1085/jgp.201812032
Keywords
-
Categories
Funding
- National Institutes of Health [NS036654, NS065371, GM103546, NS097536, NS088479]
- Janssen Pharmaceuticals
Ask authors/readers for more resources
NMDA-type glutamate receptors are ligand-gated ion channels that mediate a Ca2+-permeable component of excitatory neurotransmission in the central nervous system (CNS). They are expressed throughout the CNS and play key physiological roles in synaptic function, such as synaptic plasticity, learning, and memory. NMDA receptors are also implicated in the pathophysiology of several CNS disorders and more recently have been identified as a locus for disease-associated genomic variation. NMDA receptors exist as a diverse array of subtypes formed by variation in assembly of seven subunits (GluN1, GluN2A-D, and GluN3A-B) into tetrameric receptor complexes. These NMDA receptor subtypes show unique structural features that account for their distinct functional and pharmacological properties allowing precise tuning of their physiological roles. Here, we review the relationship between NMDA receptor structure and function with an emphasis on emerging atomic resolution structures, which begin to explain unique features of this receptor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available